KLH-conjugated synthetic peptide encompassing a sequence within the Central region of human BTBD1. The exact sequence is proprietary.
Konjugation:
Unconjugated
Alternative Synonym:
C15orf1, NS5ATP8, BTB/POZ domain-containing protein 1, Hepatitis C virus NS5A-transactivated protein 8, HCV NS5A-transactivated protein 8
The BTBD1 Antibody is suitable for FC, WB. It is a Polyclonal, Unconjugated antibody which raised against KLH-conjugated synthetic peptide encompassing a sequence within the Central region of human BTBD1. The exact sequence is proprietary. Purification: The antibody was purified by immunogen affinity chromatography.
Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.
Application Verdünnung:
WB (1/500 - 1/1000), FC (1/10 - 1/50)
Western blot analysis of BTBD1 expression in 293 (A) whole cell lysates. (Predicted band size: 52 kD, Observed band size: 55 kD)
Flow cytometric analysis of 293 cells using Anti-BTBD1 Antibody. The cells were fixed with 2% paraformaldehyde (10 min) and then permeabilized with 90% methanol for 10 min. The cells were incubated in 2% bovine serum albumin to block non-specific protein-protein interactions followed by the antibody at 37 C for 60 min. The secondary antibody Goat Anti-Rabbit IgG (H&L) - AF488 was incubated at 37 C for 40 min. Isotype control antibody (blue line) was used under the same condition.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
